Neoantigen Targeted Therapies Market Report

Global Neoantigen Targeted Therapies Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 06, 2021
  • PAGES：230
  • REPORT CODE：GMM642085
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Neoantigen Targeted Therapies is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Neoantigen Targeted Therapies market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Neoantigen Targeted Therapies industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Neoantigen Targeted Therapies Market Segmentations:

    By Players:

    • Immunovative Therapies

    • Iovance Biotherapeutics

    • Bavarian Nordic

    • Medigene

    • Precision Biologics

    • Neon Therapeutics

    • Gradalis

    • Vaxon Biotech

    • Immunicum

    • Genocea Biosciences

    By Types:

    • Monotherapy

    • Combination Therapy

    By End-User:

    • Medical Research Institution

    • Hospital and Clinic

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neoantigen Targeted Therapies Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Neoantigen Targeted Therapies Market Size and Growth Rate of Monotherapy from 2014 to 2026

      • 1.3.2 Global Neoantigen Targeted Therapies Market Size and Growth Rate of Combination Therapy from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Neoantigen Targeted Therapies Market Size and Growth Rate of Medical Research Institution from 2014 to 2026

      • 1.4.2 Global Neoantigen Targeted Therapies Market Size and Growth Rate of Hospital and Clinic from 2014 to 2026

      • 1.4.3 Global Neoantigen Targeted Therapies Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Neoantigen Targeted Therapies Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Neoantigen Targeted Therapies Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neoantigen Targeted Therapies by Major Types

      • 3.4.1 Neoantigen Targeted Therapies Market Size and Growth Rate of Monotherapy

      • 3.4.2 Neoantigen Targeted Therapies Market Size and Growth Rate of Combination Therapy

    4 Segmentation of Neoantigen Targeted Therapies Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neoantigen Targeted Therapies by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Neoantigen Targeted Therapies in Medical Research Institution

      • 4.4.2 Market Size and Growth Rate of Neoantigen Targeted Therapies in Hospital and Clinic

      • 4.4.3 Market Size and Growth Rate of Neoantigen Targeted Therapies in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Neoantigen Targeted Therapies Production Analysis by Major Regions

    • 5.2 Global Neoantigen Targeted Therapies Consumption Analysis by Major Regions

    • 5.3 Global Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

    6 Product Commodity of Neoantigen Targeted Therapies Market in Major Countries

    • 6.1 Top 5 Export Countries in Neoantigen Targeted Therapies market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neoantigen Targeted Therapies market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Neoantigen Targeted Therapies Landscape Analysis

    • 7.1 North America Neoantigen Targeted Therapies Landscape Analysis by Major Types

    • 7.2 North America Neoantigen Targeted Therapies Landscape Analysis by Major End-Users

    • 7.3 North America Neoantigen Targeted Therapies Landscape Analysis by Major Countries

      • 7.3.1 United States Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 7.3.2 Canada Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 7.3.3 Mexico Neoantigen Targeted Therapies Market Volume and Growth Rate

    8 Europe Neoantigen Targeted Therapies Landscape Analysis

    • 8.1 Europe Neoantigen Targeted Therapies Landscape Analysis by Major Types

    • 8.2 Europe Neoantigen Targeted Therapies Landscape Analysis by Major End-Users

    • 8.3 Europe Neoantigen Targeted Therapies Landscape Analysis by Major Countries

      • 8.3.1 Germany Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.2 UK Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.3 France Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.4 Italy Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.6 Spain Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.7 Belgium Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.8 Poland Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.9 Russia Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 8.3.10 Turkey Neoantigen Targeted Therapies Market Volume and Growth Rate

    9 Asia Pacific Neoantigen Targeted Therapies Landscape Analysis

    • 9.1 Asia Pacific Neoantigen Targeted Therapies Landscape Analysis by Major Types

    • 9.2 Asia Pacific Neoantigen Targeted Therapies Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Neoantigen Targeted Therapies Landscape Analysis by Major Countries

      • 9.3.1 China Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 9.3.2 Japan Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 9.3.4 India Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 9.3.6 South Korea Neoantigen Targeted Therapies Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Neoantigen Targeted Therapies Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Neoantigen Targeted Therapies Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Neoantigen Targeted Therapies Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Neoantigen Targeted Therapies Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 10.3.2 Brazil Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 10.3.3 Nigeria Neoantigen Targeted Therapies Market Volume and Growth Rate

      • 10.3.4 South Africa Neoantigen Targeted Therapies Market Volume and Growth Rate 

      • 10.3.5 Argentina Neoantigen Targeted Therapies Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Immunovative Therapies

      • 11.1.1 Immunovative Therapies Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Iovance Biotherapeutics

      • 11.2.1 Iovance Biotherapeutics Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Bavarian Nordic

      • 11.3.1 Bavarian Nordic Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Medigene

      • 11.4.1 Medigene Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Precision Biologics

      • 11.5.1 Precision Biologics Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Neon Therapeutics

      • 11.6.1 Neon Therapeutics Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Gradalis

      • 11.7.1 Gradalis Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Vaxon Biotech

      • 11.8.1 Vaxon Biotech Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Immunicum

      • 11.9.1 Immunicum Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Genocea Biosciences

      • 11.10.1 Genocea Biosciences Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 89 Figures and 171 Tables)

    • Figure Product Picture

    • Figure Neoantigen Targeted Therapies Market Size and Growth Rate of Monotherapy from 2014 to 2026

    • Figure Neoantigen Targeted Therapies Market Size and Growth Rate of Combination Therapy from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Medical Research Institution from 2014 to 2026

    • Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Hospital and Clinic from 2014 to 2026

    • Figure Global Neoantigen Targeted Therapies Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Neoantigen Targeted Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neoantigen Targeted Therapies Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neoantigen Targeted Therapies

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neoantigen Targeted Therapies by Different Types from 2014 to 2026

    • Table Consumption Share of Neoantigen Targeted Therapies by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Monotherapy

    • Figure Market Size and Growth Rate of Combination Therapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neoantigen Targeted Therapies by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neoantigen Targeted Therapies by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medical Research Institution

    • Figure Market Size and Growth Rate of Hospital and Clinic

    • Figure Market Size and Growth Rate of Other

    • Table Global Neoantigen Targeted Therapies Production by Major Regions

    • Table Global Neoantigen Targeted Therapies Production Share by Major Regions

    • Figure Global Neoantigen Targeted Therapies Production Share by Major Regions in 2014

    • Figure Global Neoantigen Targeted Therapies Production Share by Major Regions in 2018

    • Figure Global Neoantigen Targeted Therapies Production Share by Major Regions in 2026

    • Table Global Neoantigen Targeted Therapies Consumption by Major Regions

    • Table Global Neoantigen Targeted Therapies Consumption Share by Major Regions

    • Figure Global Neoantigen Targeted Therapies Consumption Share by Major Regions in 2014

    • Figure Global Neoantigen Targeted Therapies Consumption Share by Major Regions in 2018

    • Figure Global Neoantigen Targeted Therapies Consumption Share by Major Regions in 2026

    • Table North America Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

    • Table Europe Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neoantigen Targeted Therapies market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Neoantigen Targeted Therapies Consumption by Types from 2014 to 2026

    • Table North America Neoantigen Targeted Therapies Consumption Share by Types from 2014 to 2026

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Types in 2014

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Types in 2018

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Types in 2026

    • Table North America Neoantigen Targeted Therapies Consumption by End-Users from 2014 to 2026

    • Table North America Neoantigen Targeted Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure North America Neoantigen Targeted Therapies Consumption Share by End-Users in 2014

    • Figure North America Neoantigen Targeted Therapies Consumption Share by End-Users in 2018

    • Figure North America Neoantigen Targeted Therapies Consumption Share by End-Users in 2026

    • Table North America Neoantigen Targeted Therapies Consumption by Major Countries from 2014 to 2026

    • Table North America Neoantigen Targeted Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Major Countries in 2014

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Major Countries in 2018

    • Figure North America Neoantigen Targeted Therapies Consumption Share by Major Countries in 2026

    • Figure United States Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Neoantigen Targeted Therapies Consumption by Types from 2014 to 2026

    • Table Europe Neoantigen Targeted Therapies Consumption Share by Types from 2014 to 2026

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Types in 2014

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Types in 2018

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Types in 2026

    • Table Europe Neoantigen Targeted Therapies Consumption by End-Users from 2014 to 2026

    • Table Europe Neoantigen Targeted Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by End-Users in 2014

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by End-Users in 2018

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by End-Users in 2026

    • Table Europe Neoantigen Targeted Therapies Consumption by Major Countries from 2014 to 2026

    • Table Europe Neoantigen Targeted Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Major Countries in 2014

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Major Countries in 2018

    • Figure Europe Neoantigen Targeted Therapies Consumption Share by Major Countries in 2026

    • Figure Germany Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure France Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption by Types from 2014 to 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Types in 2014

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Types in 2018

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Types in 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by End-Users in 2014

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by End-Users in 2018

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by End-Users in 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Neoantigen Targeted Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Neoantigen Targeted Therapies Consumption Share by Major Countries in 2026

    • Figure China Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNeoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure India Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Neoantigen Targeted Therapies Consumption Share by Major Countries in 2026

    • Figure GCC Countries Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Neoantigen Targeted Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Immunovative Therapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunovative Therapies

    • Figure Sales and Growth Rate Analysis of Immunovative Therapies

    • Figure Revenue and Market Share Analysis of Immunovative Therapies

    • Table Product and Service Introduction of Immunovative Therapies

    • Table Company Profile and Development Status of Iovance Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iovance Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Iovance Biotherapeutics

    • Figure Revenue and Market Share Analysis of Iovance Biotherapeutics

    • Table Product and Service Introduction of Iovance Biotherapeutics

    • Table Company Profile and Development Status of Bavarian Nordic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic

    • Figure Sales and Growth Rate Analysis of Bavarian Nordic

    • Figure Revenue and Market Share Analysis of Bavarian Nordic

    • Table Product and Service Introduction of Bavarian Nordic

    • Table Company Profile and Development Status of Medigene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medigene

    • Figure Sales and Growth Rate Analysis of Medigene

    • Figure Revenue and Market Share Analysis of Medigene

    • Table Product and Service Introduction of Medigene

    • Table Company Profile and Development Status of Precision Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision Biologics

    • Figure Sales and Growth Rate Analysis of Precision Biologics

    • Figure Revenue and Market Share Analysis of Precision Biologics

    • Table Product and Service Introduction of Precision Biologics

    • Table Company Profile and Development Status of Neon Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neon Therapeutics

    • Figure Sales and Growth Rate Analysis of Neon Therapeutics

    • Figure Revenue and Market Share Analysis of Neon Therapeutics

    • Table Product and Service Introduction of Neon Therapeutics

    • Table Company Profile and Development Status of Gradalis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis

    • Figure Sales and Growth Rate Analysis of Gradalis

    • Figure Revenue and Market Share Analysis of Gradalis

    • Table Product and Service Introduction of Gradalis

    • Table Company Profile and Development Status of Vaxon Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxon Biotech

    • Figure Sales and Growth Rate Analysis of Vaxon Biotech

    • Figure Revenue and Market Share Analysis of Vaxon Biotech

    • Table Product and Service Introduction of Vaxon Biotech

    • Table Company Profile and Development Status of Immunicum

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunicum

    • Figure Sales and Growth Rate Analysis of Immunicum

    • Figure Revenue and Market Share Analysis of Immunicum

    • Table Product and Service Introduction of Immunicum

    • Table Company Profile and Development Status of Genocea Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genocea Biosciences

    • Figure Sales and Growth Rate Analysis of Genocea Biosciences

    • Figure Revenue and Market Share Analysis of Genocea Biosciences

    • Table Product and Service Introduction of Genocea Biosciences


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US